28th Sep 2006 07:00
GW Pharmaceuticals PLC28 September 2006 GW Pharmaceuticals plc Institutional Investor Site Visit Porton Down, UK, 28 September 2006 - GW Pharmaceuticals plc (AIM: GWP) will behosting an institutional investor site visit later today. The site visit willinclude presentations given by senior managers and directors on GW's operationsand strategy. There will be no discussion about current trading or futurefinancial performance. Enquiries:GW Pharmaceuticals plcDr Geoffrey Guy, Executive Chairman + 44 (0)1980 557000Justin Gover, Managing Director Financial Dynamics Tel: +44 (0)20 7831 3113David Yates, Sarah MacLeod About GW Pharmaceuticals GW was founded in 1998 and listed on the AiM, a market of the London StockExchange in June 2001. Operating under license from the UK Home Office, thecompany is developing cannabis-derived pharmaceutical products for patients withmultiple sclerosis, neuropathic pain, cancer pain, spinal cord injury,rheumatoid arthritis, and other severe medical conditions. GW has assembled a team of over 100 scientists with extensive experience indeveloping both plant-based prescription pharmaceutical products and medicinescontaining controlled substances. GW is dedicated to developing treatmentoptions that alleviate pain symptoms in patients who suffer from seriousailments. For further information, please visit the Company's website: www.gwpharm.com This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
GWP.L